MedBodh Paediatrics & Pharmacy | 22 October 2026. Safe paediatric prescribing is not simply adult prescribing with a smaller number. Children differ in body weight, developmental pharmacology, swallowing ability, organ function and exposure to excipients. WHO’s ASEAN workshop report highlights the need for coordinated systems that make appropriate paediatric medicines available and usable.
Quick note sheet
- Document: WHO technical workshop report, not a new medicine approval.
- Meeting: Kuala Lumpur, 11–13 May 2026.
- Published: October 2026.
- Core concern: child-appropriate dosage forms, access, quality and safe administration.
- Bedside rule: calculate mg first, verify actual concentration, then calculate mL.
Why children need specific formulations
Small dose volumes are vulnerable to measurement error. Some tablets cannot be safely split or crushed, particularly modified-release products. Palatability affects adherence, and certain solvents or preservatives may be unsuitable for newborns. Stock-outs can push clinicians toward nonstandard substitutions unless pharmacy review is available.
Common formulation-related risks
| Problem | Possible consequence | Prevention |
|---|---|---|
| Different liquid strengths | Two- or four-fold dosing error | Document mg/5 mL and measured mL |
| Household spoon | Inaccurate volume | Calibrated oral syringe |
| Crushed modified-release tablet | Altered drug release | Check formulation before manipulation |
| Neonatal excipient exposure | Age-specific toxicity risk | Check full product composition |
| Unreviewed substitution | Changed concentration or route | Pharmacy reconciliation |
Safe paediatric dose calculation
Step 1: confirm an indication-specific dose in mg/kg/dose or mg/kg/day. These are not equivalent. Step 2: multiply by current weight in kg, checking the maximum permitted dose. Step 3: verify the bottle’s concentration. Step 4: calculate volume and check measurability.
Arithmetic example only: if a valid prescription specifies 120 mg and the supplied suspension is 100 mg/5 mL, the concentration is 20 mg/mL and the volume is 6 mL. This example does not recommend any medicine or regimen.
Neonates and premature infants
Renal and hepatic maturation, protein binding and body-water distribution differ from older children. Gestational age and postnatal age may both matter. Do not extrapolate adult or school-age schedules to neonates; consult specialist neonatal references and the actual formulation.
Practical hospital implementation
- Maintain a paediatric formulary with approved age-specific formulations.
- Standardise electronic and paper prescriptions to show dose in mg and administration volume where relevant.
- Require independent checks for high-risk medicines and concentrations.
- Stock calibrated oral syringes and provide caregiver demonstrations.
- Review excipients and preservatives for neonates.
- Track medicine shortages and clinically reviewed substitutions.
- Report medication incidents and near misses to improve systems.
India context
The WHO workshop concerns the ASEAN region and should not be presented as a new Indian law, CDSCO approval or mandatory paediatric dose standard. Indian product labelling and local institutional policy remain essential.
Frequently asked questions
Can an adult tablet always be split for a child?
No. Release mechanism, dose uniformity and formulation suitability must be checked.
Is mg/kg/day the same as mg/kg/dose?
No. Confusing them can cause major dosing errors.
Does the WHO report provide a new antibiotic dose chart?
No. It is a medicines-systems report.
Primary source
WHO: Regional workshop on strengthening paediatric medicines ecosystems in the ASEAN region.
Clinical calculations are educational and require an authorised patient-specific prescription.